Abstract
The development of more effective antithrombotic agents with reduced side risk is necessary for the prevention of thromboembolic events. In recent years, bioactive peptides derived from food proteins have received considerable attention because of their numerous healths beneficial. Based on their amino acids sequences these peptides can exhibit various biological activities including, antihypertensive, antioxidative and antibacterial activities. Moreover, several naturally or food proteins-derived bioactive peptides that could prolong the activated partial thromboplastin time (APTT) and thrombin time (TT) have been isolated. Due to their therapeutic potential in the treatment or prevention of various diseases, bioactive peptides can be used as functional food ingredients, nutraceuticals or pharmaceuticals.
Marine organisms represent a valuable source of new bioactive substances including bioactive peptides. This paper presents an overview of the bioactive anticoagulant peptides derived from fish protein sources, as well as the enzymatic proteolysis approach used for the development of these new biopeptides.
Keywords: Biopeptide, anticoagulant, marine organisms, antithrombotic.
Current Protein & Peptide Science
Title:Marine-Derived Bioactive Peptides as New Anticoagulant Agents: A Review
Volume: 14 Issue: 3
Author(s): Rim Nasri and Moncef Nasri
Affiliation:
Keywords: Biopeptide, anticoagulant, marine organisms, antithrombotic.
Abstract: The development of more effective antithrombotic agents with reduced side risk is necessary for the prevention of thromboembolic events. In recent years, bioactive peptides derived from food proteins have received considerable attention because of their numerous healths beneficial. Based on their amino acids sequences these peptides can exhibit various biological activities including, antihypertensive, antioxidative and antibacterial activities. Moreover, several naturally or food proteins-derived bioactive peptides that could prolong the activated partial thromboplastin time (APTT) and thrombin time (TT) have been isolated. Due to their therapeutic potential in the treatment or prevention of various diseases, bioactive peptides can be used as functional food ingredients, nutraceuticals or pharmaceuticals.
Marine organisms represent a valuable source of new bioactive substances including bioactive peptides. This paper presents an overview of the bioactive anticoagulant peptides derived from fish protein sources, as well as the enzymatic proteolysis approach used for the development of these new biopeptides.
Export Options
About this article
Cite this article as:
Nasri Rim and Nasri Moncef, Marine-Derived Bioactive Peptides as New Anticoagulant Agents: A Review, Current Protein & Peptide Science 2013; 14 (3) . https://dx.doi.org/10.2174/13892037113149990042
DOI https://dx.doi.org/10.2174/13892037113149990042 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Anaesthetic Effects of Volatile Anaesthetics: A Short Trip on the Sea of Translational Medicine
Current Vascular Pharmacology Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer
Current Cancer Therapy Reviews Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Renin Inhibition as a New Strategy to Combat Cardiovascular Disease
Current Hypertension Reviews Food-derived Bioactive Peptides - Opportunities for Designing Future Foods
Current Pharmaceutical Design Hypopituitarism in Neurocritical Patients: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets The Potential of Tetrandrine Against Gliomas
Anti-Cancer Agents in Medicinal Chemistry Amniotic Fluid Embolism: Review
Current Pharmaceutical Biotechnology Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Current Pharmaceutical Design Improvement in Hypertension Management with Pharmacological and Non- Pharmacological Approaches: Current Perspectives
Current Pharmaceutical Design Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
Current Pharmaceutical Design Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Aliskiren: A Novel Renin Inhibitor for Hypertension
Current Drug Therapy Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics
Current Drug Safety Sepsis-induced Cardiomyopathy
Current Cardiology Reviews PDE-5 Inhibitors: Clinical Points
Current Drug Targets Synthesis of 5-Arylidene Barbiturates: A Novel Class of DPPH Radical Scavengers
Letters in Drug Design & Discovery Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment
Current Drug Targets From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™
Current Alzheimer Research